JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: SSR128129E (also known as SSR-128129E; SSR 128129 E) is a novel, potent, orally bioavailable and allosteric FGFR1 inhibitor with potential anticancer and anti-inflammatory activity. It inhibits FGFR1 with IC50 of 1.9 uM, while it does not affect other related RTKs. It shows high in vivo efficacy in mouse model of arthritic and mousetumor model bearing pancreatic tumor cell line Panc02, murine mammarycarcinoma cell line 4T1, murine colon cancer cell line CT26, or humanbreast MCF7/ADR cell line.
References: Cancer Cell. 2013 Apr 15; 23(4):477-88; PLoS One. 2013 Nov 4; 8(11):e80027.
Related CAS: 848318-25-2 (sodium); 848463-13-8 (free)
Chemical Name: sodium 2-amino-5-(1-methoxy-2-methylindolizine-3-carbonyl)benzoate
InChi Key: JFBMSTWZURKQOC-UHFFFAOYSA-M
InChi Code: InChI=1S/C18H16N2O4.Na/c1-10-15(20-8-4-3-5-14(20)17(10)24-2)16(21)11-6-7-13(19)12(9-11)18(22)23; /h3-9H, 19H2, 1-2H3, (H, 22, 23); /q; +1/p-1
SMILES Code: O=C([O-])C1=CC(C(C2=C(C)C(OC)=C3C=CC=CN23)=O)=CC=C1N.[Na+]
SSR 128129E; SSR-128129E; SSR128129E;
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!